TONIX PHARMACEUTICALS HOLDING CORP. Increase (Decrease) in Inventories
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Increase (Decrease) in Inventories of $534.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in inventories for the quarter ending 2026-06-30 was $2.90M, a 2133.08% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$2.37M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$364.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.22M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in inventories for fiscal 2025 was -$1.73M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in inventories for fiscal 2024 was -$3.74M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in inventories for fiscal 2023 was -$61.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $534.00K 10-Q · filed 2026-08-10 | $170.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.05M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$2.37M 10-Q · filed 2026-05-11 | -$2.73M derived: sum of 2 quarters · filed 2026-05-11 | -$3.95M derived: sum of 3 quarters · filed 2026-05-11 | -$3.82M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.58M derived: sum of 2 quarters · filed 2026-03-12 | -$1.45M derived: sum of 3 quarters · filed 2026-08-10 | -$1.73M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.09M derived: sum of 2 quarters · filed 2026-08-10 | -$1.36M 10-Q · filed 2025-11-10 | -$1.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$142.00K 10-Q · filed 2026-08-10 | -$192.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.44M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$272.00K 10-Q · filed 2026-05-11 | -$322.00K derived: sum of 2 quarters · filed 2026-05-11 | -$1.57M derived: sum of 3 quarters · filed 2026-05-11 | -$2.73M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.30M derived: sum of 2 quarters · filed 2026-03-12 | -$2.45M derived: sum of 3 quarters · filed 2026-03-12 | -$3.74M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.40M derived: sum of 2 quarters · filed 2025-11-10 | -$3.69M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$2.44M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$1.29M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$61.00K 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |